Home/ Supplements/ Boswellia/ InflammaForce

InflammaForce

product on market Capsule Energetix Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Indian Frankincense, serrapeptase, and pancreatin are utilized for their potential to modulate inflammatory responses and support enzyme-based protein breakdown. Research evidence for these specific systemic enzymes and boswellic acids is generally moderate. The formulation maintains a high safety profile with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for InflammaForce
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
90
Servings
Botanical with Nutrients
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Pancreatin 8X
200 mg
Serrapeptase
10 mg

Other Ingredients

Vegetarian Capsules Rice Starch Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

As a dietary supplement take 2 capsules three times daily or as directed by your healthcare professional.

Warnings & Precautions

Tamper-proof. Do not use if safety seal is broken or missing.

Keep out of reach of children.

Formulation Notes

Enzyme Formulation with Serrapeptase and Boswellia

Does Not Contain: Dairy or Dairy Derivatives, Stabilizers, Oils, Fats, Corn, Gluten, Maltodextrin, Salt, Alcohol, Coloring, Egg, Yeast, MSG, Irradiated Ingredients, Added Flavoring or Preservatives.

Additional Information

Store in cool, dry place out of direct sunlight.

LOT T8315 MFD MAY 2012 {recycle} Please recycle.

NUTRITIONAL

r09-11

Metadata

Product Details

UPC / SKU3 64578 13161 1
DSLD Entry Date2013-06-25
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID22826
Data Updated2026-04-11
Research

Research Evidence

33
Research Sources
55
Avg Quality
17
Systematic Review
12
Meta Analysis
3
Rct
1
Clinical Trial
A Oral herbal therapies for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
Meta Analysis Seminars in arthritis and rheumatism 2018 PubMed DOI
B Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: A systematic review and network meta-analysis
Systematic Review Complementary therapies in medicine 2026 PubMed DOI
B Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis
Meta Analysis BMC complementary medicine and therapies 2020 PubMed DOI
B Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis
Systematic Review Frontiers in pharmacology 2022 PubMed DOI
B Interventions for treating collagenous colitis
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Meta Analysis Rheumatology international 2015 PubMed DOI
B Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2017 PubMed DOI
B Frankincense: systematic review
Systematic Review BMJ (Clinical research ed.) 2008 PubMed DOI
View all evidence for Boswellia →
Compare

Similar Products

View all Boswellia products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.